FBRX (Forte Biosciences) Volatility: 97.79% (As of Jun. 26, 2026)


FBRX Forte Biosciences Inc FBRX
35 GF Score
Price $18.75
! 2 Warning Signs
View Full Analysis

What is Forte Biosciences Volatility?

Forte Biosciences FBRX +1.41% 35 Volatility is 97.79% as of Jun. 26, 2026. GuruFocus rates FBRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-26), Forte Biosciences's Volatility is 97.79%.


Forte Biosciences  (NAS:FBRX) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Forte Biosciences Volatility Related Terms


FBRX vs OABI, VNDA, ARTV: Volatility Comparison

For the Biotechnology subindustry, Forte Biosciences's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forte Biosciences Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forte Biosciences's Volatility distribution charts can be found below:

* The bar in red indicates where Forte Biosciences's Volatility falls into.


FBRX
35GF Score
Forte Biosciences Inc FBRX
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forte Biosciences  (NAS:FBRX) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 97.79% mean?
Forte Biosciences (FBRX) has a Volatility of 97.79% as of Jun. 26, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Forte Biosciences and its competitors.
Is Forte Biosciences' Volatility too high?
Forte Biosciences' current Volatility is 97.79%. Overall, Forte Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Forte Biosciences' Volatility compare to OABI and VNDA?
Forte Biosciences' Volatility of 97.79% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Forte Biosciences and its competitors. Forte Biosciences's current Volatility is 97.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forte Biosciences stock overvalued right now?
Forte Biosciences (FBRX) has a current Volatility of 97.79%. The current Volatility is 97.79%. Forte Biosciences' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Forte Biosciences (FBRX), the current Volatility is 97.79% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forte Biosciences Business Description

Other Exchanges 37T:Germany
Address 3060 Pegasus Park Drive, Building 6, Dallas, TX, USA, 75247
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
35GF Score

Get the complete analysis for FBRX

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.75
Price